Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jul 2026 for VYNE Therapeutics Inc., €18k. Read the official filing
Filing timeline
BuySaleMutya Harsch
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mutya Harsch: trading record in brief
All filings by Mutya Harsch on record concern Yarrow Bioscience, Inc., in the capacity of senior executive. We count 27 filings; the first trade dates from 30 June 2021 and the latest from 23 July 2026.
No open-market sale appears; the market trades are 1 purchase worth €23k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 26 share grants.
The latest filing, published on 24 July 2026, reports a share grant of €18k in Yarrow Bioscience, Inc. The last insider purchase was made public on 22 March 2023, 1,306 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mutya Harsch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
22,516 shares@ US$0.89760.065% mcap15.3% of flowCommon StockSEC:0001727809-26-000008:0
4,007 shares@ US$0.59752.0% of flowCommon StockSEC:0001727809-26-000004:0
3,579 shares@ US$0.58011.8% of flowCommon StockSEC:0001727809-26-000002:0
3,581 shares@ US$0.3351.1% of flowCommon StockSEC:0001727809-25-000003:0
3,581 shares@ US$1.655.3% of flowCommon StockSEC:0001415889-25-019057:0
1,145 shares@ US$0.810.9% of flowCommon StockSEC:0001415889-25-015383:0
8,828 shares@ US$1.5812.8% of flowCommon StockSEC:0001415889-25-009631:0
4,697 shares@ US$3.3515.0% of flowCommon StockSEC:0001415889-25-000154:0
105 shares@ US$1.880.2% of flowCommon StockSEC:0001415889-24-024381:0
143 shares@ US$1.920.3% of flowCommon StockSEC:0001415889-24-019174:0
161 shares@ US$3.080.5% of flowCommon StockSEC:0001415889-24-010067:0
62,500 shares0Common StockSEC:0001209191-24-000467:0
62,500 shares0Common StockSEC:0001209191-23-058817:0
1,154 shares@ US$3.834.2% of flowCommon StockSEC:0001209191-23-051944:0
157 shares@ US$4.100.6% of flowCommon StockSEC:0001209191-23-041107:0
3,664 shares@ US$3.456311.7% of flowCommon StockSEC:0001209191-23-033802:0
478 shares@ US$3.081.3% of flowCommon StockSEC:0001209191-23-022798:0
10,000 shares@ US$2.5023.2% of flowCommon StockSEC:0001209191-23-020477:0
Canonical exit: 18 Jun 2023 (T+90)
1,813 shares@ US$0.150.3% of flowCommon StockSEC:0001209191-23-001111:0
1,813 shares@ US$0.2230.4% of flowCommon StockSEC:0001209191-22-052353:0
1,813 shares@ US$0.3890.7% of flowCommon StockSEC:0001209191-22-040783:0
3,630 shares@ US$0.651.8% of flowCommon StockSEC:0001209191-22-022526:0
75,000 shares0Common StockSEC:0001209191-22-020065:0
1,484 shares@ US$1.021.2% of flowCommon StockSEC:0001209191-22-000855:0
1,484 shares@ US$1.391.5% of flowCommon StockSEC:0001209191-21-058516:0
25 of 27 declarations
